Immunogenicity of the <i>Xcl1</i>-SARS-CoV-2 Spike Fusion DNA Vaccine for COVID-19
SARS-CoV-2 spike (S) variants that may evade antibody-mediated immunity are emerging. Evidence shows that vaccines with a stronger immune response are still effective against mutant strains. Here, we report a targeted type 1 conventional dendritic (cDC1) cell strategy for improved COVID-19 vaccine d...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2022-03-01
|
| coleção: | Vaccines |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/2076-393X/10/3/407 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|